Global Nanomedicines Market to Grow at a CAGR of 11.1 Percent During Forecast Period

Strategic Insights -

The global nanomedicines market is expected to experience substantial growth, driven by innovations in nanotechnology for medicine and the rise in prevalence of various diseases. Research and Markets has predicted that the market will grow at a compound annual growth rate (CAGR) of 11.1 percent during the forecast period of 2021-2027. The market is segmented into several areas, including indication type and application, with drug delivery and cardiovascular diseases being key segments.

Key Takeaways:

  • The global nanomedicines market is projected to grow at a CAGR of 11.1 percent during the forecast period of 2021-2027.
  • Innovations in nanotechnology for medicine and the rise in prevalence of various diseases such as cardiovascular diseases, neurological diseases, and oncological diseases are major drivers of market growth.
  • The market is segmented into indication type, including cardiovascular diseases, neurological diseases, infectious diseases, and oncological diseases, with cardiovascular diseases being a significant share holder.
  • The application segment includes drug delivery, active implants, vaccines, diagnostic imaging, and biomaterials, with drug delivery being a substantial share holder.
  • The North American region is expected to hold a significant market share due to R&D activities conducted by key players.
  • 3M Co., Johnson & Johnson Services Inc., Merck & Co. Inc., Thermo Fisher Scientific Inc., AstraZeneca Plc., Celgene Corp., Pfizer Inc., Sanofi SA, and Smith & Nephew Plc are some of the prominent players in the market.

Statistics:

  • The global nanomedicines market is expected to grow at a CAGR of 11.1 percent during the forecast period of 2021-2027.
  • The market is segmented into several areas, including indication type (cardiovascular diseases, neurological diseases, infectious diseases, oncological diseases, etc.) and application (drug delivery, active implants, vaccines, diagnostic imaging, etc.).
  • The North American region is expected to hold a significant market share of 34% in 2026, while the Asia-Pacific region is expected to hold 26% of the market share.
  • The market size is expected to reach $235 billion by 2026, with a compound annual growth rate of 11.1 percent.

Sources:

  • Research and Markets: "Global Nanomedicines Market 2020-2026"
  • www.researchandmarkets.com/r/bie71a
  • "Comments on this story may be sent to newsdesk@closeupmedia.com"